Breaking

NeurologyCeASE trial tests sympathetic chain block for post-COVID condition ● PediatricsJapanese Encephalitis Study Maps Burden in Cambodian Children ● Public HealthSafer Supply Implementation Faces Barriers and Policy Gaps, Review Finds ● Medical EducationDigital simulation protocol targets professional vision in ward round communication ● PulmonologyPost-Tuberculosis Lung Disease Study Maps Imaging and Spirometry Limits ● Public HealthSocial Determinants of Health Linked to Longer, More Regular Sleep ● CardiologyCardio-mechanical dataset tracks CABG perioperative signals in coronary artery disease ● RheumatologyGut microbiota–CRAMP axis emerges as Sjögren’s disease target ●

NeurologyCeASE trial tests sympathetic chain block for post-COVID condition ● PediatricsJapanese Encephalitis Study Maps Burden in Cambodian Children ● Public HealthSafer Supply Implementation Faces Barriers and Policy Gaps, Review Finds ● Medical EducationDigital simulation protocol targets professional vision in ward round communication ● PulmonologyPost-Tuberculosis Lung Disease Study Maps Imaging and Spirometry Limits ● Public HealthSocial Determinants of Health Linked to Longer, More Regular Sleep ● CardiologyCardio-mechanical dataset tracks CABG perioperative signals in coronary artery disease ● RheumatologyGut microbiota–CRAMP axis emerges as Sjögren’s disease target ●

Advertisement

NK

Dr. A. Nikhil Krishnan, MBBS

Active Clinical Contributor & Author

Clinical Articles & Analysis by Dr. A. Nikhil Krishnan, MBBS

3571 Articles

Research Policy·NIH

NIH ends DMS plan requirement for K awards immediately

NIH has made Data Management and Sharing Plans optional for Career Development K awards, effective immediately, easing application…

Independent Review Board

All articles authored by our clinical fellows are cross-audited by MWF Review Team featuring 10 senior department chairs from premier hospitals.

Explore Review Team

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.

Advertisement

Most Read

Medicine World Foundation Alerts

Daily Clinical Dispatch

Receive peer-screened summaries across 17 clinical specialties delivered to your inbox every morning.

Trending Topics Clinical Keywords

#GLP-1 #Lecanemab #CAR-T #SepsisBundle #Semaglutide #SGLT2 #LongCOVID #AntibioticStewardship #AIDiagnostics #Statins

Advertisement

Advertisement